APLD vs. HALO
Compare and contrast key facts about Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: APLD or HALO.
Correlation
The correlation between APLD and HALO is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
APLD vs. HALO - Performance Comparison
Key characteristics
APLD:
0.51
HALO:
1.70
APLD:
1.78
HALO:
2.37
APLD:
1.21
HALO:
1.36
APLD:
0.75
HALO:
2.23
APLD:
2.56
HALO:
5.90
APLD:
28.61%
HALO:
12.84%
APLD:
144.19%
HALO:
44.56%
APLD:
-99.99%
HALO:
-74.26%
APLD:
-95.11%
HALO:
0.00%
Fundamentals
APLD:
$1.19B
HALO:
$7.56B
APLD:
-$1.47
HALO:
$3.43
APLD:
5.38
HALO:
7.38
APLD:
2.62
HALO:
20.78
APLD:
$221.19M
HALO:
$819.45M
APLD:
$12.34M
HALO:
$670.60M
APLD:
-$46.07M
HALO:
$530.80M
Returns By Period
In the year-to-date period, APLD achieves a -31.28% return, which is significantly lower than HALO's 46.71% return. Over the past 10 years, APLD has outperformed HALO with an annualized return of 110.08%, while HALO has yielded a comparatively lower 16.27% annualized return.
APLD
-31.28%
-0.19%
-25.74%
69.35%
186.65%
110.08%
HALO
46.71%
18.18%
15.69%
70.20%
24.44%
16.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
APLD vs. HALO — Risk-Adjusted Performance Rank
APLD
HALO
APLD vs. HALO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
APLD vs. HALO - Dividend Comparison
Neither APLD nor HALO has paid dividends to shareholders.
Drawdowns
APLD vs. HALO - Drawdown Comparison
The maximum APLD drawdown since its inception was -99.99%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for APLD and HALO. For additional features, visit the drawdowns tool.
Volatility
APLD vs. HALO - Volatility Comparison
Applied Digital Corporation (APLD) has a higher volatility of 54.12% compared to Halozyme Therapeutics, Inc. (HALO) at 20.39%. This indicates that APLD's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
APLD vs. HALO - Financials Comparison
This section allows you to compare key financial metrics between Applied Digital Corporation and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
APLD vs. HALO - Profitability Comparison
APLD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported a gross profit of 3.78M and revenue of 52.92M. Therefore, the gross margin over that period was 7.1%.
HALO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a gross profit of 255.95M and revenue of 298.01M. Therefore, the gross margin over that period was 85.9%.
APLD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported an operating income of -18.94M and revenue of 52.92M, resulting in an operating margin of -35.8%.
HALO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported an operating income of 175.50M and revenue of 298.01M, resulting in an operating margin of 58.9%.
APLD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported a net income of -35.56M and revenue of 52.92M, resulting in a net margin of -67.2%.
HALO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a net income of 137.01M and revenue of 298.01M, resulting in a net margin of 46.0%.